Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery

Medical University of Vienna

Status and phase: Terminated; Phase 4

Conditions: Atrial Fibrillation

Treatments: Drug: Nux vomica (active comparator); Drug: Placebo (placebo comparator)

Study type: Interventional

Funder types: Other

Identifiers

NCT00861237

2342

Details and patient eligibility

About

After heart surgery, about 30% of patients suffer from atrial fibrillation. Patients are randomized into two groups receiving either potentized Strychnos Nux vomica or placebo under double blind conditions. Postoperatively, ECGs are done to monitor cardiac rhythm.

Full description

Preoperatively, patients receive potentized Nux vomica or placebo sublingually. Then, patients are observed regarding atrial fibrillation postsurgical. The difference between the group of patients with and without nux vomica is recorded.

Enrollment: 12 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients before elective Heart valve - or aortocoronary by pass surgery with heart-lung-machine.

Exclusion criteria

• Pregnant patients
• Patients with preoperative atrial fibrillation and/or hyperthyreosis

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

12 participants in 2 patient groups, including a placebo group

Placebo globules group

Placebo Comparator group

Description:

Patients receive Placebo globules made out of sugar and looking similar to active drug sublingually before surgery.

Treatment:

Drug: Placebo (placebo comparator)

Nux vomica group

Active Comparator group

Description:

Patients receive Nux vomica globules made out of sugar sublingually before surgery.

Treatment:

Drug: Nux vomica (active comparator)